Home
Alivus Life Sciences Ltd 52 Week High

Alivus Life Sciences Ltd
NSE: ALIVUS
YEARHIGH
Key Highlights
- The 52 Week HIGH of Alivus Life Sciences Ltd is ₹ 1335 as of 15 May 25 .
Company Fundamentals for Alivus Life Sciences Ltd
Market Price of Alivus Life Sciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
15 May 2025 | 1206.2 |
14 May 2025 | 1180.6 |
13 May 2025 | 1135.05 |
12 May 2025 | 1098.1 |
09 May 2025 | 1113.9 |
08 May 2025 | 1102.2 |
07 May 2025 | 1110.95 |
06 May 2025 | 1107.25 |
05 May 2025 | 1087 |
02 May 2025 | 1088.85 |
Asset Value vs Market Value of Alivus Life Sciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Alivus Life Sciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Alivus Life Sciences Ltd
Historical Net Profit of Alivus Life Sciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Alivus Life Sciences Ltd
Alivus Life Sciences Ltd News Hub
Glenmark Life Sciences Ltd leads gainers in 'A' group
Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the oth
Read more
05 Aug 24
Glenmark Life Sciences AGM scheduled
Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will be held o
Read more
06 Sept 24
Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2
Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 September 2024.
Read more
25 Oct 24
Glenmark Life Sciences standalone net profit declines 19.72% in the September 2024 quarter
Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended Septembe
Read more
25 Oct 24